{"gene":"P2RX6","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1996,"finding":"P2X6 (P2XM/P2RX6) was cloned and expressed; it functions as an ATP-gated cation channel with two predicted transmembrane segments and a large extracellular loop, desensitizes slowly, does not respond to alpha,beta-methylene-ATP, and is not blocked by suramin or PPADS. P2X6 expressed at lower levels than P2X1-P2X4, suggesting it does not normally form homomultimeric channels.","method":"cDNA cloning, heterologous expression (Xenopus oocytes), electrophysiology, pharmacological characterization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional reconstitution in Xenopus oocytes with electrophysiology and pharmacology; foundational cloning paper replicated by multiple subsequent studies","pmids":["8786426"],"is_preprint":false},{"year":1997,"finding":"The human P2X6 gene (P2XM) is transcriptionally induced by wild-type p53, contains p53-binding sites in the genome, and is predominantly expressed in skeletal muscle. A minor splice variant lacking transmembrane domain M1 was identified, relatively more abundant in some sarcoma cell lines.","method":"p53-tagged site cloning, Northern blot analysis, RT-PCR in sarcoma cell lines","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cloning of p53-binding sites and transcriptional induction shown, but p53-driven transcription not confirmed by reporter or mutagenesis assay in this abstract","pmids":["9242461"],"is_preprint":false},{"year":1998,"finding":"P2X4 and P2X6 subunits co-assemble into a novel heteromeric ATP receptor (P2X4+6) when co-expressed in Xenopus oocytes, producing a pharmacological phenotype distinct from homomeric P2X4: activated by low-micromolar alpha,beta-methylene ATP (EC50 ~12 µM) and blocked by suramin and Reactive Blue 2. Specific co-purification from HEK-293 cells confirmed subunit-dependent physical interaction.","method":"Xenopus oocyte co-expression, electrophysiology, epitope-tagged co-purification from HEK-293 cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — functional heteromer reconstituted in oocytes and physical association confirmed by co-purification; replicated concept confirmed by subsequent AFM and Co-IP studies","pmids":["9736638"],"is_preprint":false},{"year":2000,"finding":"Co-expression of P2X2 and P2X6 subunits in Xenopus oocytes generates a heteromeric P2X2/6 receptor with distinct pharmacology from homomeric P2X2: reduced agonist potencies, biphasic ATP-evoked currents, altered pH modulation of ATP activation, and changed pH-dependent suramin blockade.","method":"Xenopus oocyte co-expression, two-electrode voltage-clamp electrophysiology, pharmacological characterization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — functional reconstitution in oocytes with detailed pharmacological characterization; single lab but multiple orthogonal measurements","pmids":["10864944"],"is_preprint":false},{"year":2004,"finding":"Functional expression of rat recombinant P2X6 receptors is regulated by N-linked glycosylation. Cells with functional P2X6 show higher molecular mass (~70 kDa vs ~60 kDa) due to increased glycosylation compared to non-functional clones; N-glycosidase F treatment collapses both to ~55 kDa. The novel functional phenotype includes sensitivity to alpha,beta-methylene ATP (EC50 ~0.6 µM). Non-functional P2X6 receptors are expressed on the membrane surface but lack the additional glycosylation present in functional receptors.","method":"Whole-cell patch-clamp electrophysiology, Western blot, N-glycosidase F treatment, surface biotinylation, RT-PCR","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal methods (glycosidase treatment, Western blot, electrophysiology) in a single study establishing N-linked glycosylation as a functional regulator","pmids":["15044628"],"is_preprint":false},{"year":2005,"finding":"P2X6 receptor subunits do not oligomerize into stable homomeric complexes when expressed alone. Chemical cross-linking of P2X6 did not produce higher-order adducts, and AFM imaging showed a mean molecular volume of only ~145 nm³ (consistent with monomer), in contrast to P2X2 which forms trimers (volume ~409 nm³).","method":"Chemical cross-linking, atomic force microscopy (AFM) imaging, anti-His6 antibody decoration","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — two orthogonal direct structural methods (cross-linking and AFM) in a single rigorous study; finding replicated conceptually by subsequent trafficking/mutation studies","pmids":["15657042"],"is_preprint":false},{"year":2006,"finding":"An uncharged 14-amino acid region at the N terminus of P2X6 inhibits its assembly and ER export, retaining the subunit as a monomer in the ER. Removal of this region or addition of charge to it allows P2X6 to form homotrimers that undergo complex glycosylation and traffic to the plasma membrane, though these N-terminal mutant homotrimers are non-functional. As a heteromer with P2X2 or P2X4, P2X6 exits the ER and is either stably expressed at the cell surface or constitutively internalized depending on the partner subunit.","method":"Immunocytochemistry, surface biotinylation, AFM, site-directed mutagenesis of N-terminus","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis combined with multiple orthogonal methods (AFM, surface biotinylation, immunocytochemistry) establishing a defined N-terminal regulatory mechanism","pmids":["16452399"],"is_preprint":false},{"year":2002,"finding":"P2X4 and P2X6 receptors co-localize with VE-cadherin at cell-cell junctions in human umbilical vein endothelial cells (HUVECs) and are rapidly internalized upon decrease in extracellular Ca2+. P2X4 (but not P2X6) could be co-immunoprecipitated with VE-cadherin, indicating P2X4 physically associates with VE-cadherin whereas P2X6 does not. Both receptors are resistant to Triton-X 100 extraction at the membrane.","method":"Confocal and electron microscopy, co-immunoprecipitation, Triton-X 100 extraction","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-localization with VE-cadherin demonstrated by microscopy; negative co-IP result for P2X6-VE-cadherin interaction is informative but P2X6 localization itself is Tier 3","pmids":["12088286"],"is_preprint":false},{"year":2014,"finding":"P2X2, P2X4, and P2X6 subunits can assemble into a heterotrimeric P2X2/4/6 receptor complex. Sequential co-immunoprecipitation using epitope-tagged subunits confirmed all three subunits interact, and AFM imaging with dual antibody decoration (anti-His6 and anti-HA Fab) identified trimeric complexes containing both P2X2 and P2X4 subunits simultaneously.","method":"Sequential co-immunoprecipitation, AFM imaging with antibody decoration, tsA201 cell expression","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal sequential co-IP combined with direct AFM structural imaging; two orthogonal methods in a single study","pmids":["24815693"],"is_preprint":false},{"year":2015,"finding":"P2X6 subunit accumulates inside the nucleus of hippocampal neurons in an age-dependent manner. Nuclear entry is facilitated by its anchorage to the ER via its N-terminal domain and requires the extracellular domain to reach the nucleus. Inside the nucleus, P2X6 shows a speckled distribution, is retained by interaction with the nuclear envelope protein spectrin α2, and interacts with splicing factor 3A1, resulting in reduced mRNA splicing activity.","method":"Immunofluorescence in hippocampal neurons, co-immunoprecipitation (spectrin α2 and SF3A1), mRNA splicing activity assay in vivo","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — nuclear localization confirmed by imaging, binding partners identified by Co-IP, and splicing activity functionally measured; single lab with multiple methods","pmids":["25874565"],"is_preprint":false},{"year":2019,"finding":"ATP activates P2RX6 to promote renal cell carcinoma (RCC) migration and invasion via Ca2+ influx that modulates ERK1/2 phosphorylation and MMP9 signaling. METTL14-mediated m6A modification of P2RX6 mRNA suppresses P2RX6 protein translation, thereby reducing ATP-P2RX6-Ca2+-pERK1/2-MMP9 signaling.","method":"In vitro migration/invasion assays, Ca2+ influx measurement, Western blot (pERK1/2, MMP9), in vivo xenograft, m6A modification analysis, METTL14 knockdown/overexpression","journal":"Journal of experimental & clinical cancer research : CR","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple in vitro and in vivo functional assays with pathway readouts; signaling cascade established but mechanistic depth of m6A-P2RX6 link relies on expression-level data","pmids":["31159832"],"is_preprint":false},{"year":2005,"finding":"TNFα inhibits the downregulation of P2X6 mRNA that normally accompanies prolonged ATP agonist exposure in cardiac fibroblasts, thereby preventing ATP-induced P2X6 desensitization and potentially maintaining Ca2+ influx leading to cell death. ATP and benzoyl-ATP-induced apoptosis in cardiac fibroblasts was exacerbated by TNFα.","method":"Primary cardiac fibroblast culture, quantitative RT-PCR, apoptosis assay, TNFα treatment","journal":"Journal of molecular and cellular cardiology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mRNA-level measurement of desensitization prevention; apoptosis assay does not confirm P2X6-specific mechanism","pmids":["16242142"],"is_preprint":false},{"year":2007,"finding":"Alternative splicing of P2X6 receptor transcripts occurs during mouse brain development and in vitro neuronal differentiation. A full-length and an alternatively spliced form were detected; the spliced form predominates during neuronal differentiation of P19 cells while the full-length form predominates in postnatal brain development.","method":"RT-PCR in P19 cells and mouse brain tissue at multiple developmental time points","journal":"Experimental physiology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — RT-PCR only, no functional validation of the alternatively spliced form's effect on channel properties","pmids":["17259301"],"is_preprint":false}],"current_model":"P2RX6 encodes an ATP-gated cation channel subunit that, uniquely among P2X family members, fails to form functional homomeric receptors due to an uncharged N-terminal region that retains monomers in the ER; it gains function by co-assembling into heteromeric channels with P2X2, P2X4, or both (P2X2/4/6 heterotrimer), and functional surface expression requires additional N-linked glycosylation; a non-canonical role involves age-dependent nuclear translocation of the P2X6 subunit, where it interacts with splicing factor 3A1 to reduce mRNA splicing activity."},"narrative":{"mechanistic_narrative":"P2RX6 encodes an ATP-gated cation channel subunit of the P2X family characterized by two predicted transmembrane segments and a large extracellular loop, with slow desensitization and an atypical pharmacology insensitive to alpha,beta-methylene-ATP, suramin, and PPADS in its initial recombinant form [PMID:8786426]. Unlike other P2X subunits, P2X6 fails to oligomerize into stable homomeric channels when expressed alone: chemical cross-linking yields no higher-order adducts and AFM shows a monomer-sized molecular volume [PMID:15657042]. This failure is imposed by an uncharged 14-amino-acid N-terminal region that blocks assembly and ER export, retaining the subunit as an ER monomer; charging or deleting this region permits homotrimer formation and surface trafficking, though such homotrimers remain non-functional [PMID:16452399]. P2X6 acquires function by co-assembling into heteromeric receptors with P2X4 (P2X4/6), P2X2 (P2X2/6), or both as a P2X2/4/6 heterotrimer, each displaying pharmacology distinct from the parent homomers [PMID:9736638, PMID:10864944, PMID:24815693]. Functional surface expression is further gated by N-linked glycosylation, with the additionally glycosylated ~70 kDa species conferring agonist sensitivity [PMID:15044628]. Beyond its channel role, P2X6 undergoes age-dependent nuclear accumulation in hippocampal neurons, where it is retained by spectrin alpha2 and interacts with splicing factor SF3A1 to reduce mRNA splicing activity [PMID:25874565]. The gene is transcriptionally induced by p53 and predominantly expressed in skeletal muscle [PMID:9242461], and ATP-driven P2RX6 signaling promotes renal cell carcinoma migration via a Ca2+-pERK1/2-MMP9 cascade controlled by METTL14-dependent m6A modification of its mRNA [PMID:31159832].","teleology":[{"year":1996,"claim":"Established that P2X6 is an ATP-gated cation channel with a distinct pharmacology, while its low expression hinted it does not normally function as a homomultimer.","evidence":"cDNA cloning and heterologous expression in Xenopus oocytes with electrophysiology and pharmacology","pmids":["8786426"],"confidence":"High","gaps":["Did not resolve subunit stoichiometry or whether homomeric channels form at all","No native tissue function established"]},{"year":1997,"claim":"Linked P2X6 transcription to p53 and localized its expression to skeletal muscle, framing it as a p53-responsive gene.","evidence":"p53-binding site cloning, Northern blot, and RT-PCR in sarcoma cell lines","pmids":["9242461"],"confidence":"Medium","gaps":["p53-driven transcription not confirmed by reporter or mutagenesis assay","Functional consequence of the M1-lacking splice variant not tested"]},{"year":1998,"claim":"Showed P2X6 gains function through heteromerization, co-assembling with P2X4 to form a receptor with novel pharmacology, answering how a weak homomer becomes physiologically relevant.","evidence":"Xenopus oocyte co-expression electrophysiology and epitope-tagged co-purification from HEK-293 cells","pmids":["9736638"],"confidence":"High","gaps":["Subunit stoichiometry of the P2X4/6 heteromer not defined","Native co-assembly in endogenous tissue not demonstrated"]},{"year":2000,"claim":"Extended the heteromer repertoire by showing P2X6 partners with P2X2 to produce a channel with altered agonist potency and pH modulation.","evidence":"Xenopus oocyte co-expression and two-electrode voltage-clamp pharmacology","pmids":["10864944"],"confidence":"High","gaps":["Single-lab characterization","Physiological context of P2X2/6 receptors not established"]},{"year":2002,"claim":"Placed P2X6 at endothelial cell-cell junctions but distinguished it from P2X4 by its inability to bind VE-cadherin, clarifying partner specificity.","evidence":"Confocal/electron microscopy, co-immunoprecipitation, and Triton extraction in HUVECs","pmids":["12088286"],"confidence":"Medium","gaps":["P2X6 junctional localization itself is lower-tier microscopy evidence","Functional role at junctions not defined"]},{"year":2004,"claim":"Identified N-linked glycosylation as a post-translational switch determining whether surface P2X6 is functional, explaining variability in recombinant channel activity.","evidence":"Whole-cell patch-clamp, Western blot, N-glycosidase F treatment, and surface biotinylation","pmids":["15044628"],"confidence":"High","gaps":["Glycosylation sites not mapped","Whether glycosylation regulates native heteromers not addressed"]},{"year":2005,"claim":"Demonstrated directly that P2X6 cannot form stable homomers, settling whether the subunit oligomerizes alone.","evidence":"Chemical cross-linking and atomic force microscopy with antibody decoration","pmids":["15657042"],"confidence":"High","gaps":["Did not identify the structural determinant blocking oligomerization","Heteromer assembly geometry not addressed"]},{"year":2005,"claim":"Suggested an inflammatory modulation of P2X6, where TNFalpha prevents agonist-induced mRNA downregulation and may sustain ATP-driven apoptosis in cardiac fibroblasts.","evidence":"Primary cardiac fibroblast culture, qRT-PCR, and apoptosis assay with TNFalpha treatment","pmids":["16242142"],"confidence":"Low","gaps":["mRNA-level measurement does not confirm a P2X6-specific channel mechanism","Apoptosis not causally linked to P2X6 activity"]},{"year":2006,"claim":"Pinpointed the uncharged 14-residue N-terminal region as the molecular cause of ER retention, mechanistically explaining why P2X6 requires a partner subunit to traffic.","evidence":"Site-directed mutagenesis of the N-terminus with immunocytochemistry, surface biotinylation, and AFM","pmids":["16452399"],"confidence":"High","gaps":["Why N-terminal mutant homotrimers remain non-functional unresolved","ER retention machinery recognizing this region not identified"]},{"year":2007,"claim":"Reported developmental alternative splicing of P2X6 transcripts in neuronal differentiation and brain maturation.","evidence":"RT-PCR in P19 cells and mouse brain at multiple time points","pmids":["17259301"],"confidence":"Low","gaps":["No functional validation of the spliced form's channel properties","RT-PCR only, no protein-level confirmation"]},{"year":2014,"claim":"Established that all three subunits can co-assemble into a single P2X2/4/6 heterotrimer, defining the most complex P2X6-containing receptor.","evidence":"Sequential co-immunoprecipitation and AFM with dual antibody decoration in tsA201 cells","pmids":["24815693"],"confidence":"High","gaps":["Functional properties of the P2X2/4/6 trimer not characterized","Native existence of this trimer not shown"]},{"year":2015,"claim":"Revealed a non-canonical nuclear role for P2X6, where age-dependent nuclear accumulation and interaction with SF3A1 reduce mRNA splicing, decoupling the subunit from channel function.","evidence":"Immunofluorescence in hippocampal neurons, co-immunoprecipitation of spectrin alpha2 and SF3A1, and in vivo splicing activity assay","pmids":["25874565"],"confidence":"Medium","gaps":["Single-lab finding without independent replication","Mechanism translating ER anchorage into nuclear entry not detailed","Physiological significance of reduced splicing not established"]},{"year":2019,"claim":"Connected P2RX6 to cancer cell behavior, showing ATP-P2RX6-Ca2+ signaling drives renal carcinoma invasion under METTL14/m6A translational control.","evidence":"Migration/invasion assays, Ca2+ imaging, Western blot for pERK1/2 and MMP9, xenografts, and m6A analysis with METTL14 manipulation","pmids":["31159832"],"confidence":"Medium","gaps":["m6A-P2RX6 link relies on expression-level data","Whether P2RX6 acts as a homomer or heteromer in this context not resolved"]},{"year":null,"claim":"The functional properties and native physiological roles of the heteromeric P2X6 receptors, and the in vivo significance of its nuclear splicing-regulatory function, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of any P2X6-containing channel","Endogenous tissue expression of specific heteromers undefined","Causal disease role not established by genetic evidence"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,3,4]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,6]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,3,10]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0]}],"complexes":["P2X4/6 heteromeric receptor","P2X2/6 heteromeric receptor","P2X2/4/6 heterotrimeric receptor"],"partners":["P2RX4","P2RX2","SF3A1","SPTAN1","CDH5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O15547","full_name":"P2X purinoceptor 6","aliases":["ATP receptor","P2XM","Purinergic receptor","Purinergic receptor P2X-like 1"],"length_aa":441,"mass_kda":48.8,"function":"May act as a modulatory subunit rather than a functional channel. Unlike other P2XRs members, P2RX6 does not seem to form functional homotrimers (PubMed:22378790). P2RX6 requires the presence of P2RX4 or P2RX2 to shuttle it to the plasma membrane where it may form functional heterotrimeric receptors at the plasma membrane (PubMed:22378790). P2RX6 can be translocated to the nucleus and functions as a nuclear regulator of post-transcriptional modifications in neurons (By similarity)","subcellular_location":"Cell membrane; Endoplasmic reticulum; Nucleus; Nucleus inner membrane","url":"https://www.uniprot.org/uniprotkb/O15547/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P2RX6","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P2RX6","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skeletal muscle","ntpm":31.7},{"tissue":"tongue","ntpm":11.1}],"url":"https://www.proteinatlas.org/search/P2RX6"},"hgnc":{"alias_symbol":["P2XM","MGC129625","P2X6"],"prev_symbol":["P2RXL1"]},"alphafold":{"accession":"O15547","domains":[{"cath_id":"1.10.287","chopping":"30-61_335-374","consensus_level":"high","plddt":89.9053,"start":30,"end":374},{"cath_id":"2.60.490.10","chopping":"73-121_194-332","consensus_level":"high","plddt":91.7714,"start":73,"end":332}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15547","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15547-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15547-F1-predicted_aligned_error_v6.png","plddt_mean":82.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P2RX6","jax_strain_url":"https://www.jax.org/strain/search?query=P2RX6"},"sequence":{"accession":"O15547","fasta_url":"https://rest.uniprot.org/uniprotkb/O15547.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15547/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15547"}},"corpus_meta":[{"pmid":"8786426","id":"PMC_8786426","title":"Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8786426","citation_count":768,"is_preprint":false},{"pmid":"9736638","id":"PMC_9736638","title":"Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9736638","citation_count":204,"is_preprint":false},{"pmid":"15657042","id":"PMC_15657042","title":"Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15657042","citation_count":157,"is_preprint":false},{"pmid":"10864944","id":"PMC_10864944","title":"Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10864944","citation_count":105,"is_preprint":false},{"pmid":"31159832","id":"PMC_31159832","title":"The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31159832","citation_count":100,"is_preprint":false},{"pmid":"9242461","id":"PMC_9242461","title":"Cloning of P2XM, a novel human P2X receptor gene regulated by p53.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9242461","citation_count":73,"is_preprint":false},{"pmid":"15044628","id":"PMC_15044628","title":"Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel alpha beta-methylene ATP-sensitive phenotype.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15044628","citation_count":61,"is_preprint":false},{"pmid":"16452399","id":"PMC_16452399","title":"An uncharged region within the N terminus of the P2X6 receptor inhibits its assembly and exit from the endoplasmic reticulum.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16452399","citation_count":53,"is_preprint":false},{"pmid":"10633863","id":"PMC_10633863","title":"Expression of two ATP-gated ion channels, P2X5 and P2X6, in developing chick skeletal muscle.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10633863","citation_count":47,"is_preprint":false},{"pmid":"12088286","id":"PMC_12088286","title":"P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells.","date":"2002","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/12088286","citation_count":46,"is_preprint":false},{"pmid":"16242142","id":"PMC_16242142","title":"P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death.","date":"2005","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/16242142","citation_count":45,"is_preprint":false},{"pmid":"19946698","id":"PMC_19946698","title":"Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract.","date":"2009","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19946698","citation_count":39,"is_preprint":false},{"pmid":"17259301","id":"PMC_17259301","title":"Alternative splicing of P2X6 receptors in developing mouse brain and during in vitro neuronal differentiation.","date":"2007","source":"Experimental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17259301","citation_count":30,"is_preprint":false},{"pmid":"11591462","id":"PMC_11591462","title":"Immunoreactivity to P2X(6) receptors in the rat hypothalamo-neurohypophysial system: an ultrastructural study with extravidin and colloidal gold-silver labelling.","date":"2001","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11591462","citation_count":27,"is_preprint":false},{"pmid":"24815693","id":"PMC_24815693","title":"Identification of P2X2/P2X4/P2X6 heterotrimeric receptors using atomic force microscopy (AFM) imaging.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24815693","citation_count":19,"is_preprint":false},{"pmid":"10376970","id":"PMC_10376970","title":"Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.","date":"1999","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10376970","citation_count":13,"is_preprint":false},{"pmid":"12713031","id":"PMC_12713031","title":"Expression of P2X6, a purinergic receptor subunit, is affected by dietary zinc deficiency in rat hippocampus.","date":"2003","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/12713031","citation_count":12,"is_preprint":false},{"pmid":"25874565","id":"PMC_25874565","title":"Age-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25874565","citation_count":11,"is_preprint":false},{"pmid":"27254077","id":"PMC_27254077","title":"P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27254077","citation_count":10,"is_preprint":false},{"pmid":"9852680","id":"PMC_9852680","title":"Cloning and characterization of the murine P2XM receptor gene.","date":"1998","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9852680","citation_count":9,"is_preprint":false},{"pmid":"38392191","id":"PMC_38392191","title":"Next Generation Sequencing and Electromyography Reveal the Involvement of the P2RX6 Gene in Myopathy.","date":"2024","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38392191","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11908,"output_tokens":3540,"usd":0.044412,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11168,"output_tokens":3945,"usd":0.077232,"stage2_stop_reason":"end_turn"},"total_usd":0.121644,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"P2X6 (P2XM/P2RX6) was cloned and expressed; it functions as an ATP-gated cation channel with two predicted transmembrane segments and a large extracellular loop, desensitizes slowly, does not respond to alpha,beta-methylene-ATP, and is not blocked by suramin or PPADS. P2X6 expressed at lower levels than P2X1-P2X4, suggesting it does not normally form homomultimeric channels.\",\n      \"method\": \"cDNA cloning, heterologous expression (Xenopus oocytes), electrophysiology, pharmacological characterization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional reconstitution in Xenopus oocytes with electrophysiology and pharmacology; foundational cloning paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"8786426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The human P2X6 gene (P2XM) is transcriptionally induced by wild-type p53, contains p53-binding sites in the genome, and is predominantly expressed in skeletal muscle. A minor splice variant lacking transmembrane domain M1 was identified, relatively more abundant in some sarcoma cell lines.\",\n      \"method\": \"p53-tagged site cloning, Northern blot analysis, RT-PCR in sarcoma cell lines\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cloning of p53-binding sites and transcriptional induction shown, but p53-driven transcription not confirmed by reporter or mutagenesis assay in this abstract\",\n      \"pmids\": [\"9242461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"P2X4 and P2X6 subunits co-assemble into a novel heteromeric ATP receptor (P2X4+6) when co-expressed in Xenopus oocytes, producing a pharmacological phenotype distinct from homomeric P2X4: activated by low-micromolar alpha,beta-methylene ATP (EC50 ~12 µM) and blocked by suramin and Reactive Blue 2. Specific co-purification from HEK-293 cells confirmed subunit-dependent physical interaction.\",\n      \"method\": \"Xenopus oocyte co-expression, electrophysiology, epitope-tagged co-purification from HEK-293 cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — functional heteromer reconstituted in oocytes and physical association confirmed by co-purification; replicated concept confirmed by subsequent AFM and Co-IP studies\",\n      \"pmids\": [\"9736638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Co-expression of P2X2 and P2X6 subunits in Xenopus oocytes generates a heteromeric P2X2/6 receptor with distinct pharmacology from homomeric P2X2: reduced agonist potencies, biphasic ATP-evoked currents, altered pH modulation of ATP activation, and changed pH-dependent suramin blockade.\",\n      \"method\": \"Xenopus oocyte co-expression, two-electrode voltage-clamp electrophysiology, pharmacological characterization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional reconstitution in oocytes with detailed pharmacological characterization; single lab but multiple orthogonal measurements\",\n      \"pmids\": [\"10864944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Functional expression of rat recombinant P2X6 receptors is regulated by N-linked glycosylation. Cells with functional P2X6 show higher molecular mass (~70 kDa vs ~60 kDa) due to increased glycosylation compared to non-functional clones; N-glycosidase F treatment collapses both to ~55 kDa. The novel functional phenotype includes sensitivity to alpha,beta-methylene ATP (EC50 ~0.6 µM). Non-functional P2X6 receptors are expressed on the membrane surface but lack the additional glycosylation present in functional receptors.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology, Western blot, N-glycosidase F treatment, surface biotinylation, RT-PCR\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal methods (glycosidase treatment, Western blot, electrophysiology) in a single study establishing N-linked glycosylation as a functional regulator\",\n      \"pmids\": [\"15044628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2X6 receptor subunits do not oligomerize into stable homomeric complexes when expressed alone. Chemical cross-linking of P2X6 did not produce higher-order adducts, and AFM imaging showed a mean molecular volume of only ~145 nm³ (consistent with monomer), in contrast to P2X2 which forms trimers (volume ~409 nm³).\",\n      \"method\": \"Chemical cross-linking, atomic force microscopy (AFM) imaging, anti-His6 antibody decoration\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — two orthogonal direct structural methods (cross-linking and AFM) in a single rigorous study; finding replicated conceptually by subsequent trafficking/mutation studies\",\n      \"pmids\": [\"15657042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"An uncharged 14-amino acid region at the N terminus of P2X6 inhibits its assembly and ER export, retaining the subunit as a monomer in the ER. Removal of this region or addition of charge to it allows P2X6 to form homotrimers that undergo complex glycosylation and traffic to the plasma membrane, though these N-terminal mutant homotrimers are non-functional. As a heteromer with P2X2 or P2X4, P2X6 exits the ER and is either stably expressed at the cell surface or constitutively internalized depending on the partner subunit.\",\n      \"method\": \"Immunocytochemistry, surface biotinylation, AFM, site-directed mutagenesis of N-terminus\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis combined with multiple orthogonal methods (AFM, surface biotinylation, immunocytochemistry) establishing a defined N-terminal regulatory mechanism\",\n      \"pmids\": [\"16452399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"P2X4 and P2X6 receptors co-localize with VE-cadherin at cell-cell junctions in human umbilical vein endothelial cells (HUVECs) and are rapidly internalized upon decrease in extracellular Ca2+. P2X4 (but not P2X6) could be co-immunoprecipitated with VE-cadherin, indicating P2X4 physically associates with VE-cadherin whereas P2X6 does not. Both receptors are resistant to Triton-X 100 extraction at the membrane.\",\n      \"method\": \"Confocal and electron microscopy, co-immunoprecipitation, Triton-X 100 extraction\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-localization with VE-cadherin demonstrated by microscopy; negative co-IP result for P2X6-VE-cadherin interaction is informative but P2X6 localization itself is Tier 3\",\n      \"pmids\": [\"12088286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"P2X2, P2X4, and P2X6 subunits can assemble into a heterotrimeric P2X2/4/6 receptor complex. Sequential co-immunoprecipitation using epitope-tagged subunits confirmed all three subunits interact, and AFM imaging with dual antibody decoration (anti-His6 and anti-HA Fab) identified trimeric complexes containing both P2X2 and P2X4 subunits simultaneously.\",\n      \"method\": \"Sequential co-immunoprecipitation, AFM imaging with antibody decoration, tsA201 cell expression\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal sequential co-IP combined with direct AFM structural imaging; two orthogonal methods in a single study\",\n      \"pmids\": [\"24815693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"P2X6 subunit accumulates inside the nucleus of hippocampal neurons in an age-dependent manner. Nuclear entry is facilitated by its anchorage to the ER via its N-terminal domain and requires the extracellular domain to reach the nucleus. Inside the nucleus, P2X6 shows a speckled distribution, is retained by interaction with the nuclear envelope protein spectrin α2, and interacts with splicing factor 3A1, resulting in reduced mRNA splicing activity.\",\n      \"method\": \"Immunofluorescence in hippocampal neurons, co-immunoprecipitation (spectrin α2 and SF3A1), mRNA splicing activity assay in vivo\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — nuclear localization confirmed by imaging, binding partners identified by Co-IP, and splicing activity functionally measured; single lab with multiple methods\",\n      \"pmids\": [\"25874565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATP activates P2RX6 to promote renal cell carcinoma (RCC) migration and invasion via Ca2+ influx that modulates ERK1/2 phosphorylation and MMP9 signaling. METTL14-mediated m6A modification of P2RX6 mRNA suppresses P2RX6 protein translation, thereby reducing ATP-P2RX6-Ca2+-pERK1/2-MMP9 signaling.\",\n      \"method\": \"In vitro migration/invasion assays, Ca2+ influx measurement, Western blot (pERK1/2, MMP9), in vivo xenograft, m6A modification analysis, METTL14 knockdown/overexpression\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple in vitro and in vivo functional assays with pathway readouts; signaling cascade established but mechanistic depth of m6A-P2RX6 link relies on expression-level data\",\n      \"pmids\": [\"31159832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TNFα inhibits the downregulation of P2X6 mRNA that normally accompanies prolonged ATP agonist exposure in cardiac fibroblasts, thereby preventing ATP-induced P2X6 desensitization and potentially maintaining Ca2+ influx leading to cell death. ATP and benzoyl-ATP-induced apoptosis in cardiac fibroblasts was exacerbated by TNFα.\",\n      \"method\": \"Primary cardiac fibroblast culture, quantitative RT-PCR, apoptosis assay, TNFα treatment\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mRNA-level measurement of desensitization prevention; apoptosis assay does not confirm P2X6-specific mechanism\",\n      \"pmids\": [\"16242142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Alternative splicing of P2X6 receptor transcripts occurs during mouse brain development and in vitro neuronal differentiation. A full-length and an alternatively spliced form were detected; the spliced form predominates during neuronal differentiation of P19 cells while the full-length form predominates in postnatal brain development.\",\n      \"method\": \"RT-PCR in P19 cells and mouse brain tissue at multiple developmental time points\",\n      \"journal\": \"Experimental physiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — RT-PCR only, no functional validation of the alternatively spliced form's effect on channel properties\",\n      \"pmids\": [\"17259301\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P2RX6 encodes an ATP-gated cation channel subunit that, uniquely among P2X family members, fails to form functional homomeric receptors due to an uncharged N-terminal region that retains monomers in the ER; it gains function by co-assembling into heteromeric channels with P2X2, P2X4, or both (P2X2/4/6 heterotrimer), and functional surface expression requires additional N-linked glycosylation; a non-canonical role involves age-dependent nuclear translocation of the P2X6 subunit, where it interacts with splicing factor 3A1 to reduce mRNA splicing activity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"P2RX6 encodes an ATP-gated cation channel subunit of the P2X family characterized by two predicted transmembrane segments and a large extracellular loop, with slow desensitization and an atypical pharmacology insensitive to alpha,beta-methylene-ATP, suramin, and PPADS in its initial recombinant form [#0]. Unlike other P2X subunits, P2X6 fails to oligomerize into stable homomeric channels when expressed alone: chemical cross-linking yields no higher-order adducts and AFM shows a monomer-sized molecular volume [#5]. This failure is imposed by an uncharged 14-amino-acid N-terminal region that blocks assembly and ER export, retaining the subunit as an ER monomer; charging or deleting this region permits homotrimer formation and surface trafficking, though such homotrimers remain non-functional [#6]. P2X6 acquires function by co-assembling into heteromeric receptors with P2X4 (P2X4/6), P2X2 (P2X2/6), or both as a P2X2/4/6 heterotrimer, each displaying pharmacology distinct from the parent homomers [#2, #3, #8]. Functional surface expression is further gated by N-linked glycosylation, with the additionally glycosylated ~70 kDa species conferring agonist sensitivity [#4]. Beyond its channel role, P2X6 undergoes age-dependent nuclear accumulation in hippocampal neurons, where it is retained by spectrin alpha2 and interacts with splicing factor SF3A1 to reduce mRNA splicing activity [#9]. The gene is transcriptionally induced by p53 and predominantly expressed in skeletal muscle [#1], and ATP-driven P2RX6 signaling promotes renal cell carcinoma migration via a Ca2+-pERK1/2-MMP9 cascade controlled by METTL14-dependent m6A modification of its mRNA [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that P2X6 is an ATP-gated cation channel with a distinct pharmacology, while its low expression hinted it does not normally function as a homomultimer.\",\n      \"evidence\": \"cDNA cloning and heterologous expression in Xenopus oocytes with electrophysiology and pharmacology\",\n      \"pmids\": [\"8786426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve subunit stoichiometry or whether homomeric channels form at all\", \"No native tissue function established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Linked P2X6 transcription to p53 and localized its expression to skeletal muscle, framing it as a p53-responsive gene.\",\n      \"evidence\": \"p53-binding site cloning, Northern blot, and RT-PCR in sarcoma cell lines\",\n      \"pmids\": [\"9242461\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"p53-driven transcription not confirmed by reporter or mutagenesis assay\", \"Functional consequence of the M1-lacking splice variant not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed P2X6 gains function through heteromerization, co-assembling with P2X4 to form a receptor with novel pharmacology, answering how a weak homomer becomes physiologically relevant.\",\n      \"evidence\": \"Xenopus oocyte co-expression electrophysiology and epitope-tagged co-purification from HEK-293 cells\",\n      \"pmids\": [\"9736638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit stoichiometry of the P2X4/6 heteromer not defined\", \"Native co-assembly in endogenous tissue not demonstrated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Extended the heteromer repertoire by showing P2X6 partners with P2X2 to produce a channel with altered agonist potency and pH modulation.\",\n      \"evidence\": \"Xenopus oocyte co-expression and two-electrode voltage-clamp pharmacology\",\n      \"pmids\": [\"10864944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-lab characterization\", \"Physiological context of P2X2/6 receptors not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed P2X6 at endothelial cell-cell junctions but distinguished it from P2X4 by its inability to bind VE-cadherin, clarifying partner specificity.\",\n      \"evidence\": \"Confocal/electron microscopy, co-immunoprecipitation, and Triton extraction in HUVECs\",\n      \"pmids\": [\"12088286\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"P2X6 junctional localization itself is lower-tier microscopy evidence\", \"Functional role at junctions not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified N-linked glycosylation as a post-translational switch determining whether surface P2X6 is functional, explaining variability in recombinant channel activity.\",\n      \"evidence\": \"Whole-cell patch-clamp, Western blot, N-glycosidase F treatment, and surface biotinylation\",\n      \"pmids\": [\"15044628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Glycosylation sites not mapped\", \"Whether glycosylation regulates native heteromers not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated directly that P2X6 cannot form stable homomers, settling whether the subunit oligomerizes alone.\",\n      \"evidence\": \"Chemical cross-linking and atomic force microscopy with antibody decoration\",\n      \"pmids\": [\"15657042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the structural determinant blocking oligomerization\", \"Heteromer assembly geometry not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Suggested an inflammatory modulation of P2X6, where TNFalpha prevents agonist-induced mRNA downregulation and may sustain ATP-driven apoptosis in cardiac fibroblasts.\",\n      \"evidence\": \"Primary cardiac fibroblast culture, qRT-PCR, and apoptosis assay with TNFalpha treatment\",\n      \"pmids\": [\"16242142\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"mRNA-level measurement does not confirm a P2X6-specific channel mechanism\", \"Apoptosis not causally linked to P2X6 activity\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Pinpointed the uncharged 14-residue N-terminal region as the molecular cause of ER retention, mechanistically explaining why P2X6 requires a partner subunit to traffic.\",\n      \"evidence\": \"Site-directed mutagenesis of the N-terminus with immunocytochemistry, surface biotinylation, and AFM\",\n      \"pmids\": [\"16452399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why N-terminal mutant homotrimers remain non-functional unresolved\", \"ER retention machinery recognizing this region not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Reported developmental alternative splicing of P2X6 transcripts in neuronal differentiation and brain maturation.\",\n      \"evidence\": \"RT-PCR in P19 cells and mouse brain at multiple time points\",\n      \"pmids\": [\"17259301\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional validation of the spliced form's channel properties\", \"RT-PCR only, no protein-level confirmation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that all three subunits can co-assemble into a single P2X2/4/6 heterotrimer, defining the most complex P2X6-containing receptor.\",\n      \"evidence\": \"Sequential co-immunoprecipitation and AFM with dual antibody decoration in tsA201 cells\",\n      \"pmids\": [\"24815693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional properties of the P2X2/4/6 trimer not characterized\", \"Native existence of this trimer not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed a non-canonical nuclear role for P2X6, where age-dependent nuclear accumulation and interaction with SF3A1 reduce mRNA splicing, decoupling the subunit from channel function.\",\n      \"evidence\": \"Immunofluorescence in hippocampal neurons, co-immunoprecipitation of spectrin alpha2 and SF3A1, and in vivo splicing activity assay\",\n      \"pmids\": [\"25874565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without independent replication\", \"Mechanism translating ER anchorage into nuclear entry not detailed\", \"Physiological significance of reduced splicing not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected P2RX6 to cancer cell behavior, showing ATP-P2RX6-Ca2+ signaling drives renal carcinoma invasion under METTL14/m6A translational control.\",\n      \"evidence\": \"Migration/invasion assays, Ca2+ imaging, Western blot for pERK1/2 and MMP9, xenografts, and m6A analysis with METTL14 manipulation\",\n      \"pmids\": [\"31159832\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"m6A-P2RX6 link relies on expression-level data\", \"Whether P2RX6 acts as a homomer or heteromer in this context not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The functional properties and native physiological roles of the heteromeric P2X6 receptors, and the in vivo significance of its nuclear splicing-regulatory function, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of any P2X6-containing channel\", \"Endogenous tissue expression of specific heteromers undefined\", \"Causal disease role not established by genetic evidence\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 3, 4]},\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 3, 10]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\n      \"P2X4/6 heteromeric receptor\",\n      \"P2X2/6 heteromeric receptor\",\n      \"P2X2/4/6 heterotrimeric receptor\"\n    ],\n    \"partners\": [\n      \"P2RX4\",\n      \"P2RX2\",\n      \"SF3A1\",\n      \"SPTAN1\",\n      \"CDH5\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":7,"faith_pct":71.42857142857143}}